<DOC>
	<DOCNO>NCT00884039</DOCNO>
	<brief_summary>This study investigate use anecortave acetate injection reduce intraocular pressure ( IOP ) corneal transplant recipient experience steroid-associated pressure control problem . Alternative method IOP control show entail serious risk . For example , reduction topical steroid increase risk graft rejection , use glaucoma medication glaucoma surgery increase risk graft failure . This study design sufficient power detect whether single injection induce clinically significant IOP reduction .</brief_summary>
	<brief_title>Anecortave Acetate Injection Treat Steroid-responsive Intraocular Pressure Increase Cornea Transplant Patients</brief_title>
	<detailed_description />
	<mesh_term>Anecortave</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>least 18 year age corneal transplant recipient intraocular pressure ( IOP ) great 24 mmHg relative increase IOP least 10 mmHg pregraft baseline pregnant lactate intraocular surgery study eye within 30 day enrol study use investigational drug treatment within 30 day receipt study medication clinical evidence scleral thinning</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>cornea</keyword>
	<keyword>transplant</keyword>
	<keyword>intraocular pressure</keyword>
	<keyword>steroid response</keyword>
</DOC>